osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
12 1260-1268[1998]
a novel secreted protein involved in the regulation of bone density
89 309-319[1997]
Type I collagen: Structure, synthesis and regulation.
1 -[2002]
The molecular clock mediates leptin-regulated bone formation
122 803-815[2005]
The biochemistry of bone
1 107-188[2001]
TRANCE is a TNF family member that regulates dendritic cell and osteoclast function
65 715-724[1999]
Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/ osteoprotegerin
247 610-615[1998]
Role of osteoblasts in hormonal control of bone resorption--a hypothesis
349-351[1981]
Rates of bone loss in the appendicular and axial skeletons of women Evidence of substantial vertebral bone loss before menopause
1487-1491[1986]
RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism
97 1566-1571[2000]
RANK is essential for osteoclast and lymph node development
13 2412-2424[1999]
Quantitative computed tomography of vertebral spon- giosa a sensitive method for detecting early bone loss after oophorectomy
699-705[1982]
Parathyroid hormone stimulates bone formation and resorption in organ culture evidence for a coupling mechanism
3204-3208[1981]
Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release
2398-2402[1989]
Osteoprotegerin ligand: a common link between osteoclastogenesis, lymph node formation and lymphocyte development
77 188--193[1999]
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
93 165-176[1998]
Osteopontin and related phosphorylated sialoproteins
760 249-256[1995]
Osteoclastogenesis inhibitory factor exhibits hypocalcemic effects in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy
23 495-498[1998]
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
397 315-323[1999]
Mineralization by matrix vesicles
-964[1984]
Mineral and collagen-binding proteins of fetal calf bone
10403-10408[1981]
Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone
89 180--190[2003]
Mechanism of calcification role of collagen fibrils and collagen-phosphoprotein complexes in vitro and in vivo
139-153[1989]
Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse
endocri logy 127 2592-2594[1990]
Leptin regulation of bone resorption by the sympathetic nervous system and CART
434 514-520[2005]
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development.
107 513-523[2001]
Is all bone the same? Distinctive distributions and properties of non-collagenous matrix proteins in lamellar vs woven bone imply the existence of different underlying osteogenic mechanisms
9 201-223[1998]
Inhibition of TGF-beta receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass
126 4267- 4279[1999]
Infusions of recombinant human interleukins 1 alpha and 1 beta cause hypercalcemia in normal mice
5235-5239[1988]
Induction of osteoclast differentiation by Runx2 through receptor activator of nuclear factor- kappaB ligand and osteoprotegerin regulation and partial rescue of osteoclastogenesis in Runx2-/- mice by RANKL transgene
278 23971-23977[2003]
In vivo stimulation of bone formation by transforming growth factor-beta
endocri- logy 124 2991-2994[1989]
Identifying genes that regulate bone remo- deling as potential therapeutic targets
201 841-843[2005]
Hypocalcemic effect of osteoclastogenesis inhibitory factor/osteoprotegerin in the thyroparathyroidectomized rat
139 4012-4015[1998]
Growth factors regulate the synthesis of insulin-like growth factor-I in bone cell cultures
endocri logy 133 33-38[1993]
Growth factors and the regulation of bone remodeling
277-281[1988]
Extracellular matrix and biomineralization of bone
38-46[2003]
Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shed- ding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival.
274 13613-13618[1999]
Dynamics of bone remodeling
315-[1964]
Characterization of the latent transforming growth factor beta complex in bone
49-58[1990]
Characterization of native and recombinant bone sialoprotein delineation of the mineral-binding and cell adhesion domains and structural analysis of the RGD domain
12 1210-1222[1997]
Basic principles and clinical applications of biochemical markers of bone metabolism
2 299-321[1999]
A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait